Talk:Robert Ira Lewy
From Wikipedia, the free encyclopedia
I have amended the title of the article to reflect the contents. Thank you Kingseason 18:20, 16 January 2007 (UTC)
- What is the title you intend for the article to be? We can move it there for you. Leebo86 18:22, 16 January 2007 (UTC)
Robert Ira Lewy, M.D. , F.A.C.P.,; Education, Contributions to Role of Aspirin Therapy in Heart Disease and Allergic Phenomena in Recipients of Silicone Breast Implants, and Philanthropic Activities
- Okay, I'm going to move the page to Robert Ira Lewy. We'll continue the necessary notability discussion then. Leebo86 18:26, 16 January 2007 (UTC)
Thank you. IK have reviewed the notability tests. Kingseason 18:31, 16 January 2007 (UTC)
- I haven't gone through the text of the article yet, but do you feel confident that Robert Ira Lewy does in fact meet at least one of the notability requirements? If he does, we can start cleaning it up. I think you would benefit from reviewing the Wikipedia Manual of Style. Leebo86 18:37, 16 January 2007 (UTC)
Yes, I think it meets at least the "Professor Test" for notability. Best.Kingseason 18:43, 16 January 2007 (UTC) Also, publications were all during the period when the author was Clinical Assistant Professor of Medicine at twso medical schools, though this title is not stated in the article.Kingseason 18:45, 16 January 2007 (UTC) This author has other publications which have not been cited as well. Kingseason 18:47, 16 January 2007 (UTC) Notability: Dr Lewy has published at least 25 scientific papers and chapters which are annotated in his article. Therefore he meets the Professor criterion for Notability, having published at least as much as a tenured professor would over this time period. In fact, he was Associate Professor of Medicine at two medical schools during this period, as above. Such articles are accepted for publication based on their importance (as well as methodology) by scientific editorial boards and jurors. Beyond this, his work has been subject of praise and regard by his peers in editorials (cited) and newspapers (cited). Therefore, his work will be "permanent". As research in the use of platelet blocking agents for heart disease progresses (indeed, much has been done in this area triggered by his articles since publication, such as the licensing of drugs based on his work),his contributions will worthy of reference and repetition.Kingseason 20:57, 9 February 2007 (UTC)
[edit] Articles for Deletion debate
This article survived an Articles for Deletion debate. The discussion can be found here. -Splash - tk 23:11, 15 April 2007 (UTC)